|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Gross Sales | |||||
| Allowances | |||||
| Total Net Sales | |||||
| Cost of sales | |||||
| Gross Profit | |||||
| Operating expenses | |||||
| Impairment of goodwill and other intangible assets | |||||
| Loss from operations | |||||
| Realized and Unrealized gain (loss) on marketable and other securities, including impairments | |||||
| Gain (loss) on sale of assets | |||||
| Restructuring expense | |||||
| Realized and unrealized loss on marketable and other securities, including impairments | |||||
| Decrease of contingent liability | |||||
| Other income | |||||
| Increase in fair value of convertible debt | |||||
| Interest income (expense) | |||||
| Loss before provision for income taxes | |||||
| Benefit (expense) for income taxes | |||||
| Net Loss | |||||
| Preferred dividends | |||||
| Net Loss attributable to common shareholders | |||||
| Net Loss per share: | |||||
| Basic and Diluted earnings per share (in dollars per share) | |||||
| Weighted average number of shares Basic and Diluted: (in shares) | |||||
Loading...